185 related articles for article (PubMed ID: 38233678)
1. Guillain-Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis.
Censi S; Bisaccia G; Gallina S; Tomassini V; Uncini A
J Neurol; 2024 Mar; 271(3):1063-1071. PubMed ID: 38233678
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
Osowicki J; Morgan HJ; Harris A; Clothier HJ; Buttery JP; Kiers L; Crawford NW;
Vaccine; 2022 Dec; 40(52):7579-7585. PubMed ID: 36357291
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
[TBL] [Abstract][Full Text] [Related]
5. Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines: A Nationwide Self-Controlled Case Series Study.
Le Vu S; Bertrand M; Botton J; Jabagi MJ; Drouin J; Semenzato L; Weill A; Dray-Spira R; Zureik M
Neurology; 2023 Nov; 101(21):e2094-e2102. PubMed ID: 37788935
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines.
García-Grimshaw M; Galnares-Olalde JA; Bello-Chavolla OY; Michel-Chávez A; Cadena-Fernández A; Briseño-Godínez ME; Antonio-Villa NE; Núñez I; Gutiérrez-Romero A; Hernández-Vanegas L; Del Mar Saniger-Alba M; Carrillo-Mezo R; Ceballos-Liceaga SE; Carbajal-Sandoval G; Flores-Silva FD; Díaz-Ortega JL; Cortes-Alcalá R; Pérez-Padilla JR; López-Gatell H; Chiquete E; Reyes-Terán G; Arauz A; Valdés-Ferrer SI
Eur J Neurol; 2022 Nov; 29(11):3368-3379. PubMed ID: 35841212
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database.
Keh RYS; Scanlon S; Datta-Nemdharry P; Donegan K; Cavanagh S; Foster M; Skelland D; Palmer J; Machado PM; Keddie S; Carr AS; Lunn MP;
Brain; 2023 Feb; 146(2):739-748. PubMed ID: 35180300
[TBL] [Abstract][Full Text] [Related]
8. Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States.
Abara WE; Gee J; Marquez P; Woo J; Myers TR; DeSantis A; Baumblatt JAG; Woo EJ; Thompson D; Nair N; Su JR; Shimabukuro TT; Shay DK
JAMA Netw Open; 2023 Feb; 6(2):e2253845. PubMed ID: 36723942
[TBL] [Abstract][Full Text] [Related]
9. Real-world data on the incidence and risk of Guillain-Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study.
Ha J; Park S; Kang H; Kyung T; Kim N; Kim DK; Kim H; Bae K; Song MC; Lee KJ; Lee E; Hwang BS; Youn J; Seok JM; Park K
Sci Rep; 2023 Mar; 13(1):3773. PubMed ID: 36882454
[TBL] [Abstract][Full Text] [Related]
10. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
Kim JE; Park J; Min YG; Hong YH; Song TJ
J Peripher Nerv Syst; 2022 Sep; 27(3):206-214. PubMed ID: 35751472
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data.
Atzenhoffer M; Auffret M; Pegat A; Masmoudi K; Khouri C; Bertin B; Vial T
Clin Drug Investig; 2022 Jul; 42(7):581-592. PubMed ID: 35676452
[TBL] [Abstract][Full Text] [Related]
12. Guillain-Barré syndrome in an era of global infections and 21st century vaccination.
Lunn MP
Curr Opin Neurol; 2022 Oct; 35(5):571-578. PubMed ID: 36069416
[TBL] [Abstract][Full Text] [Related]
13. Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review.
Lee HY; Lien WC
Hum Vaccin Immunother; 2023 Dec; 19(1):2171231. PubMed ID: 36919452
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome after COVID-19 vaccines: A Tunisian case series.
Berrim K; Lakhoua G; Zaiem A; Charfi O; Aouinti I; Kastalli S; Daghfous R; El Aidli S
Br J Clin Pharmacol; 2023 Feb; 89(2):574-578. PubMed ID: 36398559
[TBL] [Abstract][Full Text] [Related]
15. No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study.
Jaffry M; Mostafa F; Mandava K; Rosario S; Jagarlamudi Y; Jaffry K; Kornitzer J; Jedidi K; Khan H; Souayah N
Vaccine; 2022 Sep; 40(40):5791-5797. PubMed ID: 36055875
[TBL] [Abstract][Full Text] [Related]
16. Post-marketing active surveillance of Guillain Barré Syndrome following COVID-19 vaccination in persons aged ≥12 years in Italy: A multi-database self-controlled case series study.
Morciano C; Spila Alegiani S; Menniti Ippolito F; Belleudi V; Trifirò G; Zanoni G; Puccini A; Sapigni E; Mores N; Leoni O; Monaco G; Clagnan E; Zappetti C; Bovo E; Cutillo M; Da Cas R; Massari M
PLoS One; 2024; 19(1):e0290879. PubMed ID: 38241309
[TBL] [Abstract][Full Text] [Related]
17. Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.
Walker JL; Schultze A; Tazare J; Tamborska A; Singh B; Donegan K; Stowe J; Morton CE; Hulme WJ; Curtis HJ; Williamson EJ; Mehrkar A; Eggo RM; Rentsch CT; Mathur R; Bacon S; Walker AJ; Davy S; Evans D; Inglesby P; Hickman G; MacKenna B; Tomlinson L; Ca Green A; Fisher L; Cockburn J; Parry J; Hester F; Harper S; Bates C; Evans SJ; Solomon T; Andrews NJ; Douglas IJ; Goldacre B; Smeeth L; McDonald HI
Vaccine; 2022 Jul; 40(32):4479-4487. PubMed ID: 35715350
[TBL] [Abstract][Full Text] [Related]
18. Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study.
Bishara H; Arbel A; Barnett-Griness O; Bloch S; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
Neurology; 2023 Nov; 101(20):e2035-e2042. PubMed ID: 37852786
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2.
Leung C
Hum Vaccin Immunother; 2021 Sep; 17(9):2957-2958. PubMed ID: 34032555
[TBL] [Abstract][Full Text] [Related]
20. Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021.
Lehmann HC; Oberle D; Keller-Stanislawski B; Rieck T; Streit R
Euro Surveill; 2023 Jun; 28(24):. PubMed ID: 37318764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
